Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease - Quiz - MDSpire

Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease

  • By

  • Ning Lyu

  • Michaela Tracy

  • Sebastian Schneeweiss

  • Timothy J. Savage

  • July 10, 2026

  • 0 min

Share

Original Source(s)

Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease

  • by Ning Lyu, Michaela Tracy, Sebastian Schneeweiss, Timothy J. Savage

  • July 10, 2026

Related Content

Evidence-based summary of optimal home self-management for elderly ostomy patients

Malignancy as a rising contributor to mortality in patients with inflammatory bowel disease: a population-based epidemiological study

Escalating anti-tumour necrosis factor exposure with reductions in surgical resection rates in paediatric inflammatory bowel disease: an 18-year real-world population-based cohort study